CAS 57381-37-0
:2-Bromo-5-chlorobenzonitrile
- Benzonitrile, 2-bromo-5-chloro-
- 2-Bromo-5-chlorobenzonitrile
2-Bromo-5-chlorobenzonitrile
CAS:Formula:C7H3BrClNPurity:98%Color and Shape:SolidMolecular weight:216.46242-Bromo-5-chlorobenzonitrile
CAS:2-Bromo-5-chlorobenzonitrileFormula:C7H3BrClNPurity:≥95%Color and Shape: off white powderMolecular weight:216.46g/mol2-Bromo-5-chlorobenzonitrile
CAS:Formula:C7H3BrClNPurity:95%Color and Shape:Solid, Off-white powderMolecular weight:216.462-Bromo-5-chlorobenzonitrile
CAS:2-Bromo-5-chlorobenzonitrile (2BC) is a synthetic drug that has been used in the treatment of neuropsychiatric disorders. It is a glutamate receptor subtype agonist, which activates the metabotropic glutamate receptor. 2BC binds to the pyridinium site of the mGluR5 subtype, inhibiting glutamate binding and preventing activation of ion channels. The benzothiazole moiety has been found to be essential for this activity. 2BC also has antiviral properties and can inhibit HIV replication in vitro.
2BC is currently being explored as a potential therapeutic agent for schizophrenia and other neuropsychiatric disorders that involve glutamatergic dysfunction such as depression, bipolar disorder, and anxiety disorder.br>br>
br>br>
Potential side effects include sedation, dizziness, blurred vision, headache, drowsiness, fatigue, nausea/vomiting and increased appetite.Formula:C7H3BrClNPurity:Min. 95%Color and Shape:PowderMolecular weight:216.46 g/mol



